Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Front Biosci (Elite Ed). 2012 Jan 1;4:1478–1495. doi: 10.2741/474

Table 4.

Alternative promoter and alternative splicing regulate the expression and structures of IL-17 cytokines and receptors

A. Alternative promoter and alternative splicing regulate the expression and structures of IL-17 Cytokines
Gene Exon(s) Total Isoform(s) ORF Isoform(s) IL-17 domain /secreted Promoter(s)
IL-17A 3 1 1 1 1
IL-17B 6 3 3 2 2
IL-17C 4 2 2 1 1
IL-17D 8 5 5 2 3
IL-17E 3 2 2 2 1
IL-17F 3 2 2 1 2
IL-17a 3 1 1 1 1
IL-17b 8 7 7 4 4
IL-17c 2 1 1 1 1
IL-17d 3 3 2 2 1
IL-17e 3 1 1 1 1
IL-17f 9 4 4 2 2
B. Alternative promoter and alternative splicing regulate the expression and structures of IL-17 receptors
Gene Exon(s) Total Isoform(s) ORF Isoform(s) Secreted SEFIR domain Promoter(s)
IL-17RA 33 23 18 <18 3
IL-17RB 11 2 1 1 11
IL-17RC 39 28 26 5 <26 4
IL-17RD 18 5 4 <4 1
IL-17RE 13 1 1 1 11
IL-17ra 14 4 3 1 <3 1
IL-17rb 11 1 1 1 11
IL-17rc 20 7 7 <7 2
IL-17rd 12 1 1 1 11
IL-17re 23 11 11 3 <11 2

Of note: The data were retrieved from the NIH-NCBI-AceView database except those marked with 1, which were retrieved from the NIH-NCBI-Gene database. AceView-NCBI database was used to examine alternative promoter and alternative spliced isoforms of genes. A majority of the IL-17 cytokine and receptor genes in both human and mouse has numerous isoforms. Many of the genes have alternative promoters and more than one open reading frame (ORF) suggesting that alternative promoters and alternative splicing regulate the structure and expression of IL-17 cytokines and receptors. Human cytokine and receptor family members are designated with capital letters while mouse cytokine and receptor family members are denoted with lowercase letters.